JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paxton, J R
Right arrow Articles by Burnett, R A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paxton, J R
Right arrow Articles by Burnett, R A
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Cervical Cancer
J Clin Pathol 2000; 53:197-200
© 2000 Journal of Clinical Pathology

Apoptosis in cervical squamous carcinoma: predictive value for survival following radiotherapy

J R Paxton1, B S Bolger2, A Armour3, R P Symonds3, J H Mao3, R A Burnett1

1 Department of Pathology, Western Infirmary, Glasgow G11 6NT, UK
2 Department of Pathology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK
3 Beatson Oncology Centre, Western Infirmary, Glasgow G11 6NT, UK

Dr Paxton Background—Apoptosis, or programmed cell death, can be induced by radiotherapy. The extent of apoptosis in a tumour before treatment may have important implications for response to radiotherapy and long term survival.

Aim—To examine the extent of apoptosis in tumour tissue from patients with squamous carcinoma of the cervix before radiotherapy, and to correlate this with response to treatment and prognosis.

Methods—The percentage of apoptotic cells was assessed in 146 carcinomas of the cervix from patients scheduled to receive radiotherapy. The CAS 200 static image analysis system was used to count the number of tumour nuclei per high power field, while the numbers of apoptotic cells in the same field were visualised simultaneously on the image analyser and recorded manually.

Results—The median apoptotic level was 0.73%. Patients were divided into two groups around the median. There was no statistically significant difference in outcome between the two groups as determined by long term survival following radiotherapy.

Conclusions—The CAS 200 static image analyser system can be used to assist in the rapid semiautomated assessment of apoptosis in conventionally prepared tissue. The results suggest that the apoptotic state of a tumour before treatment is of no value in predicting response to radiotherapy and subsequent prognosis. Tumour stage, size, and BrdU labelling index, as a measure of proliferation rate, remain the most important prognostic factors in terms of predicting local tumour control.

Key Words: apoptosis • uterine cervix • squamous cell carcinoma




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
G Van de Putte, R Holm, A K Lie, M Baekelandt, and G B Kristensen
Markers of apoptosis in stage IB squamous cervical carcinoma
J. Clin. Pathol., June 1, 2005; 58(6): 590 - 594.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. W. Tsang, S. Juvet, M. Pintilie, R. P. Hill, C. S. Wong, M. Milosevic, W. Chapman, and A. W. Fyles
Pretreatment Proliferation Parameters Do Not Add Predictive Power to Clinical Factors in Cervical Cancer Treated with Definitive Radiation Therapy
Clin. Cancer Res., October 1, 2003; 9(12): 4387 - 4395.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Tezuka, H. Watanabe, S. Nakamura, D. Yu, W. Aung, T. Sasaki, H. Shibuya, and M. Miura
Antiapoptotic Activity Is Dispensable for Insulin-like Growth Factor I Receptor-mediated Clonogenic Radioresistance after {gamma}-Irradiation
Clin. Cancer Res., October 1, 2001; 7(10): 3206 - 3214.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.